Travere Therapeutics, Inc.TVTXNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank93
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$22.22M
↑ 115% vs avg
Percentile
P93
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$-145.69M
Historical baseline
PeriodValueYoY Change
TTM$22.22M+108.4%
2024$-265.77M+18.5%
2023$-326.25M-9.0%
2022$-299.42M-62.3%
2021$-184.46M-27.1%
2020$-145.16M-35.4%
2019$-107.21M-46.1%
2018$-73.39M-89.8%
2017$-38.67M+0.3%
2016$-38.79M-